Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?


Creative Commons License

El-Khouly F. E., van Zanten S. E. M. V., Santa-Maria Lopez V., Hendrikse N. H., Kaspers G. J. L., Loizos G., ...Daha Fazla

JOURNAL OF NEURO-ONCOLOGY, cilt.145, sa.1, ss.177-184, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 145 Sayı: 1
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1007/s11060-019-03287-9
  • Dergi Adı: JOURNAL OF NEURO-ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.177-184
  • Anahtar Kelimeler: Diffuse intrinsic pontine glioma (DIPG), Diffuse midline glioma H3-K27 mutant (DMG K3-27M), Chemotherapy, Radiotherapy, BRAIN-STEM GLIOMA, CHILDREN, COHORT, PROGNOSIS, TUMORS
  • İstanbul Üniversitesi Adresli: Evet

Özet

Introduction Diffuse intrinsic pontine glioma (DIPG) is a rare clinically, neuro-radiologically, and molecularly defined malignancy of the brainstem with a median overall survival of approximately 11 months. Our aim is to evaluate the current tendency for its treatment in Europe in order to develop (inter)national consensus guidelines.